Apolipoprotein B mRNA Editing and the Reduction in Synthesis and Secretion of the Atherogenic Risk Factor, Apolipoprotein B100 Can Be Effectively Targeted through TAT-Mediated Protein Transduction

2002 ◽  
Vol 61 (2) ◽  
pp. 269-276 ◽  
Author(s):  
Yan Yang ◽  
Nazzareno Ballatori ◽  
Harold C. Smith
Lipids ◽  
1996 ◽  
Vol 31 (4) ◽  
pp. 433-436 ◽  
Author(s):  
Fatiha Nassir ◽  
Federico Giannoni ◽  
Andrzej Mazur ◽  
Yves Rayssiguier ◽  
Nicholas O. Davidson

2020 ◽  
Vol 10 (23) ◽  
pp. 8681
Author(s):  
Manabu Niimi ◽  
Yajie Chen ◽  
Haizhao Yan ◽  
Yao Wang ◽  
Tomonari Koike ◽  
...  

Hyperlipidemia or dyslipidemia is a major risk factor for atherosclerotic diseases. Experimental animals play an important role in elucidating the molecular mechanisms of the pathophysiology of hyperlipidemia as well as in drug development. Rabbits are one of the most suitable models to study human hyperlipidemia because many features of the lipoprotein metabolism of rabbits are similar to those of humans such as LDL-rich lipoproteins in plasma, apolipoprotein B mRNA editing, and cholesteryl ester transfer protein. Currently, three types of rabbit models are commonly used for studying hyperlipidemia: (1) diet-induced hyperlipidemic rabbits, (2) spontaneous hyperlipidemic rabbits, and (3) gene-manipulated rabbits (transgenic and knockout rabbits). In this review, we give an overview of the features of hyperlipidemic rabbits and discuss the usefulness of rabbits for the development of anti-atherogenic drugs.


1999 ◽  
Vol 40 (4) ◽  
pp. 623-635 ◽  
Author(s):  
Ba-Bie Teng ◽  
Scott Ochsner ◽  
Qian Zhang ◽  
Kizhake V. Soman ◽  
Paul P. Lau ◽  
...  

1990 ◽  
Vol 265 (36) ◽  
pp. 22446-22452 ◽  
Author(s):  
K Boström ◽  
Z Garcia ◽  
K S Poksay ◽  
D F Johnson ◽  
A J Lusis ◽  
...  

2018 ◽  
pp. 297-317
Author(s):  
Nicholas O. Davidson

Sign in / Sign up

Export Citation Format

Share Document